ProKidney Corp (PROK)

Sector:
FINANCE
Industry:
GENERAL FINANCE
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Timothy A. Bertram
Employees:
3
2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
336-999-7028

ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.

Data derived from most recent annual or quarterly report
Market Cap 1.094 Billion Shares Outstanding232.264 Million Avg 30-day Volume 650.587 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price to Revenue0.0 Debt to Equity0.0 EBITDA-143.226 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value2.056 Billion
Current Ratio19.04 EPS Growth0 Quick Ratio18.212
1 Yr BETA 1.039 52-week High/Low 14.19 / 3.95 Profit Margin0.0
Operating Cash Flow Growth0.0 Free Cash Flow to Firm (FCFF) TTM 0 Free Cash Flow to Equity (FCFE) TTM-107.858 Million
Altman Z-Score12.0761
Earnings Report2023-11-13
View SEC Filings from PROK instead.

View recent insider trading info

ProKidney Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding PROK (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PROK

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-08-29 by WEBER DARIN J.
  • 4: filed on 2023-08-03 by CULLETON BRUCE
  • 3: filed on 2023-07-25 by CULLETON BRUCE
  • 4: filed on 2023-07-03 by JIMENEZ SANTOS JOSE IGNACIO
  • 4: filed on 2023-04-04 by COWEN AARON
  • 4: filed on 2023-01-18 by WEGER MARY
  • 4: filed on 2023-01-18 by WEBER DARIN J.
  • 4: filed on 2023-01-18 by MCKENZIE LIBBIE PARKER
  • 4: filed on 2023-01-18 by JAIN DEEPAK
  • 4: filed on 2023-01-18 by GIROLAMO TODD C

    • Events (8k)

  • 8-K: filed on 2023-09-11:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-08-10:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-07-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-06-30:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2023-06-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-05-11:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-06:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-06:
    Item 8.01: Other Events
  • 8-K: filed on 2023-01-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    1.7 Million total shares from 1 transactions

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    PALIHAPITIYA CHAMATH

    SC MASTER HOLDINGS, LLC

    • 10% Owner
    		 14,573,000 2023-09-19 1

    WEBER DARIN J. SVP OF REGULATORY DEVELOPMENT

    • Officer
    		 137,000 2023-08-25 3

    CULLETON BRUCE EVP, CLINICAL DEVELOPMENT

    • Officer
    		 0 2023-08-01 2

    FOX JENNIFER A.

    • Director
    		 0 2023-07-12 1

    MARAGANORE JOHN

    • Director
    		 0 2023-06-29 1

    DOYLE WILLIAM F

    • Director
    		 0 2023-06-29 1

    PEREIRA BRIAN JG

    • Director
    		 0 2023-06-29 1

    LOTVIN ALAN

    • Director
    		 0 2023-06-29 1

    LEGORRETA PABLO G.

    • Director
    • 10% Owner
    		 0 2023-06-29 1

    SINHA UMA

    • Director
    		 0 2023-06-29 1

    JIMENEZ SANTOS JOSE IGNACIO

    • Director
    		 0 2023-06-29 1

    COWEN AARON

    • 10% Owner
    		 4,050,675 2023-03-31 1

    BERTRAM TIMOTHY CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 1,011,500 2023-01-16 2

    WEGER MARY CHIEF PEOPLE OFFICER

    • Officer
    		 185,000 2023-01-16 3

    GIROLAMO TODD C CHIEF LEGAL OFFICER

    • Officer
    		 290,000 2023-01-16 2

    COULSTON JAMES CHIEF FINANCIAL OFFICER

    • Officer
    		 290,000 2023-01-16 2

    MCKENZIE LIBBIE PARKER CHIEF MEDICAL OFFICER

    • Officer
    		 250,000 2023-01-16 2

    JAIN DEEPAK CHIEF OPERATING OFFICER

    • Officer
    		 585,000 2023-01-16 2

    CONTROL EMPRESARIAL DE CAPITALES S.A. DE C.V.

    • 10% Owner
    		 0 2022-07-11 0

    LEGORRETA PABLO G.

    TOLERANTIA, LLC

    • Director
    • 10% Owner
    		 0 2022-07-11 1

    PALIHAPITIYA CHAMATH

    • 10% Owner
    		 38,273,000 2022-07-11 1

    SCS SPONSOR III LLC

    MEHTA KISHAN

    COWEN AARON

    CHACHACHA DNA III, LLC

    • FORMER DIRECTOR AND 10% OWNERFORMER DIRECTOR AND 10% OWNERFORMER DIRECTOR AND 10% OWNERFORMER DIRECTOR AND 10% OWNER
    		 0 2022-07-11 0

    SC MASTER HOLDINGS, LLC

    SC PIPE HOLDINGS LLC

    • 10% Owner
    		 13,273,000 2022-07-11 0

    SCS SPONSOR III LLC

    PALIHAPITIYA CHAMATH CHIEF EXECUTIVE OFFICER

    MEHTA KISHAN PRESIDENT

    COWEN AARON

    CHACHACHA DNA III, LLC

    • Officer
    • Director
    • 10% Owner
    		 6,220,000 2021-08-16 1

    SEMIGRAN MARC

    • Director
    		 0 2021-06-29 0

    RYANS JAMES CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2021-06-29 0

    KATZ SHONEY DIRECTOR OF RESEARCH

    • Officer
    		 0 2021-06-29 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    PALIHAPITIYA CHAMATH - > 10% Owner see footnote

    SC MASTER HOLDINGS, LLC - > 10% Owner see footnote

    		2023-09-21 17:00:16 -0400 2023-09-19 S 1,700,000 $5.47 d 2,073,000 indirect -8.9027 0.0 1 -8.9027 2

    WEBER DARIN J. - Officer SVP OF REGULATORY DEVELOPMENT

    		2023-08-29 21:25:00 -0400 2023-08-25 C 137,000 a 137,000 direct -4.5606 -11.3459 0.0 1 -11.3459 6

    WEBER DARIN J. - Officer SVP OF REGULATORY DEVELOPMENT

    		2023-08-29 21:25:00 -0400 2023-08-25 C 137,000 d 539,356 direct

    WEBER DARIN J. - Officer SVP OF REGULATORY DEVELOPMENT

    		2023-08-29 21:25:00 -0400 2023-08-25 C 137,000 d 539,356 direct

    CULLETON BRUCE - Officer EVP, CLINICAL DEVELOPMENT

    		2023-08-03 08:52:29 -0400 2023-08-01 A 485,000 a 485,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    PROKIDNEY CORP PROK 2023-09-29 22:15:03 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 21:45:04 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 21:15:03 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 20:45:05 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 20:15:04 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 19:45:04 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 19:15:03 UTC 0.0 0.0 30000
    PROKIDNEY CORP PROK 2023-09-29 18:45:03 UTC 0.0 0.0 30000
    PROKIDNEY CORP PROK 2023-09-29 18:15:03 UTC 0.0 0.0 30000
    PROKIDNEY CORP PROK 2023-09-29 17:45:03 UTC 0.0 0.0 30000
    PROKIDNEY CORP PROK 2023-09-29 17:15:04 UTC 0.0 0.0 30000
    PROKIDNEY CORP PROK 2023-09-29 16:45:04 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 16:15:03 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 15:45:04 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 15:15:04 UTC -0.3977 5.7177 30000
    PROKIDNEY CORP PROK 2023-09-29 14:45:04 UTC -0.4111 5.7311 30000
    PROKIDNEY CORP PROK 2023-09-29 14:15:04 UTC -0.4111 5.7311 30000
    PROKIDNEY CORP PROK 2023-09-29 13:45:03 UTC -0.24 5.56 30000
    PROKIDNEY CORP PROK 2023-09-29 13:15:04 UTC -0.24 5.56 30000
    PROKIDNEY CORP PROK 2023-09-29 12:45:05 UTC -0.24 5.56 30000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments